Level IIB dissection in early stages cT1-T2 oral squamous cell carcinomas: pros and cons - 29/07/21

Doi : 10.1016/j.jormas.2021.07.005

Hugo Frandjian ^a,^b,^⁎ , Aline van Maanen ^c,^d, Pierre Mahy ^b,^d, Laurent Guyot ^a,^e, Nicolas Graillon ^f,^g, Michèle Magremanne ^b,^d
^a Department of oral and maxillofacial surgery, CHU Conception, AP–HM, 147, boulevard Baille, 13005 Marseille, France
^b Department of oral and maxillo-facial surgery, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, 10, avenue Hippocrate, 1200 Brussels,Belgium
^c Statistical support unit, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, 10, avenue Hippocrate, 1200 Brussels, Belgium
^d Institut Roi Albert II, Cancérologie et Hématologie, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, 10, avenue Hippocrate, 1200 Brussels, Belgium
^e CNRS, EFS, ADES, Aix-Marseille university, boulevard Pierre-Dramard, 13344 Marseille, France
^f Aix Marseille Univ., APHM, LBA, La Conception University Hospital, Department of Oral and Maxillofacial Surgery, Marseille, France
^g IFSTTAR, LBA UMR_T24, Aix-Marseille university, boulevard Pierre-Dramard, 13916 Marseille, France

^⁎Corresponding author at: Department of stomatology and maxillo-facial surgery, Hôpital de la Conception, Université Aix-Marseille, 13005, France.Department of stomatology and maxillo-facial surgeryHôpital de la ConceptionUniversité Aix-Marseille13005France

En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Thursday 29 July 2021
This article has been published in an issue click here to access